Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer.
S. J. Wong
Research Funding - Roche
J. Moughan
No relevant relationships to disclose
N. J. Meropol
Consultant or Advisory Role - Genentech
P. R. Anne
No relevant relationships to disclose
L. A. Kachnic
No relevant relationships to disclose
A. Rashid
No relevant relationships to disclose
J. C. Watson
No relevant relationships to disclose
E. P. Mitchell
No relevant relationships to disclose
J. Pollock
No relevant relationships to disclose
M. G. Haddock
No relevant relationships to disclose
B. Erickson
No relevant relationships to disclose
C. G. Willett
No relevant relationships to disclose